Filing Details
- Accession Number:
- 0001237899-12-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-08 10:35:02
- Reporting Period:
- 2012-02-06
- Filing Date:
- 2012-02-08
- Accepted Time:
- 2012-02-08 10:35:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance And Admin Cfo Trea | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-06 | 18,750 | $16.80 | 105,861 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-06 | 3,206 | $98.23 | 102,655 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-02-06 | 7,160 | $98.23 | 95,495 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2012-02-06 | 9,375 | $21.25 | 104,870 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-06 | 2,027 | $98.23 | 102,843 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-02-06 | 3,384 | $98.23 | 99,459 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2012-02-06 | 12,788 | $24.86 | 112,247 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-06 | 3,236 | $98.23 | 109,011 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-02-06 | 4,400 | $98.23 | 104,611 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-02-07 | 13,265 | $99.67 | 91,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-07 | 3,735 | $100.42 | 87,611 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-07 | 500 | $101.35 | 87,111 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-06 | 18,750 | $0.00 | 18,750 | $16.80 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-06 | 9,375 | $0.00 | 9,375 | $21.25 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-06 | 12,788 | $0.00 | 12,788 | $24.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,048 | 2018-12-17 | No | 4 | M | Direct | |
| 23,420 | 2019-12-18 | No | 4 | M | Direct | |
| 0 | 2010-07-05 | 2014-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,416 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 13,265 shares of Company stock on February 7, 2012 at prices ranging from $99.22 to $99.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2012 at each separate price.
- Represents volume-weighted average price of sales of 3,735 shares of Company stock on February 7, 2012 at prices ranging from $100.00 to $100.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2012 at each separate price.
- Represents volume-weighted average price of sales of 500 shares of Company stock on February 7, 2012 at prices ranging from $101.33 to $101.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2012 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
